Cover Image

A Dataset for Constructing the Network Pharmacology of Overactive Bladder and Its Application to Reveal the Potential Therapeutic Targets of Rhynchophylline

<b>Objectives</b>: Network pharmacology is essential for understanding the multi-target and multi-pathway therapeutic mechanisms of traditional Chinese medicine. This study aims to evaluate the influence of database quality on target identification and to explore the therapeutic potentia...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yan Tie (Author), Jihan Liu (Author), Yushan Wu (Author), Yining Qiang (Author), Ge'Er Cai'Li (Author), Pingxiang Xu (Author), Ming Xue (Author), Liping Xu (Author), Xiaorong Li (Author), Xuelin Zhou (Author)
Format:	Book
Published:	MDPI AG, 2024-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Daidzein is the in vivo active compound of Puerariae Lobatae Radix water extract for muscarinic receptor-3 inhibition against overactive bladder
by: Yining Qiang, et al.
Published: (2022)

Anti-Hypoxic Molecular Mechanisms of Rhodiola crenulata Extract in Zebrafish as Revealed by Metabonomics
by: Yi Ma, et al.
Published: (2019)

Overactive bladder
by: Anna Zwierzyńska
Published: (2021)

The Experimental overactive bladder modelling
by: O. I. Iatsyna, et al.
Published: (2018)

The Experimental overactive bladder modelling
by: O. I. Iatsyna, et al.
Published: (2018)

OVERACTIVE BLADDER SYNDROME IN CHILDREN
by: E.L. Vishnevskiy
Published: (2007)

OVERACTIVE BLADDER SYNDROME IN CHILDREN
by: E.L. Vishnevskiy
Published: (2007)

Overactive bladder: An underestimated troublesome problem in women
by: Yiu-Tai Li, et al.
Published: (2022)

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity
by: Stacey Tannenbaum, et al.
Published: (2020)

Rhynchophylline Attenuates Senescence of Endothelial Progenitor Cells by Enhancing Autophagy
by: Lin Lin, et al.
Published: (2020)

Chapter Biomarkers in the Overactive Bladder Syndrome
by: Silva, Carlos
Published: (2012)

Chapter Biomarkers in the Overactive Bladder Syndrome
by: Silva, Carlos
Published: (2012)

New in the diagnosis of overactive bladder (review)
by: F N Mahmedzhanova, et al.
Published: (2013)

Mirabegron in the Management of Overactive Bladder Syndrome
by: O'Kane M, et al.
Published: (2022)

Clinical Correlation Between Overactive Bladder and Allergy in Children
by: Lu Yin, et al.
Published: (2022)

The application of botulinum toxin in the treatment of overactive bladder
by: Justyna Wojcik, et al.
Published: (2020)

The overactive bladder model anatomical and morphological correlates
by: O. I. Iatsyna
Published: (2018)

The overactive bladder model anatomical and morphological correlates
by: O. I. Iatsyna
Published: (2018)

Fesoterodine for the treatment of urinary incontinence and overactive bladder
by: Pamela Ellsworth
Published: (2009)

The Association of Bladder Wall Thickness with Severity of Symptoms in Patients with Overactive Bladder
by: Ronny Adrian, et al.
Published: (2017)

Learning Curve of Botulinum Toxin Bladder Injection for the Treatment of Refractory Overactive Bladder
by: Barba M, et al.
Published: (2022)

Treatment efficacy of tolterodine versus belladonna mixture in children with idiopathic overactive bladder
by: Zheming Xu, et al.
Published: (2019)

Overactive bladder (OAB) in women: questionnaire based approach
by: Veena Ganju Malla, et al.
Published: (2020)

Clinical and urodynamic effects of tolterodine in women with an overactive bladder
by: Chiu-Lin Wang, et al.
Published: (2013)

Literature Review: Quality of Life in Patients with Overactive Bladder
by: Vitaria Wahyu Astuti, et al.
Published: (2022)

An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder
by: Frankel J, et al.
Published: (2022)

Profile of mirabegron in the treatment of overactive bladder: place in therapy
by: Sharaf A, et al.
Published: (2017)

Medicinal plants and natural products for treating overactive bladder
by: Huanxian Chen, et al.
Published: (2024)

Pharmacoeconomic feasibility of using Mirabegron in patients with overactive bladder
by: I. N. Dyakov, et al.
Published: (2021)

Celastrol and Rhynchophylline in the mitigation of simulated muscle atrophy under in vitro
by: Maksymilian Wastag, et al.
Published: (2022)

Evaluation of quality of life in women with overactive bladder (a survey)
by: F N Makhmejanova
Published: (2014)

Relationship between anxiety and overactive bladder syndrome in older women
by: Aline Teixeira Alves, et al.
Published: (2014)

A promising protein responsible for overactive bladder in ovariectomized mice
by: Huey-Yi Chen, et al.
Published: (2017)

Assessing Quality-of-Life of Patients Taking Mirabegron for Overactive Bladder
by: Shaw C, et al.
Published: (2023)

Childhood nocturnal enuresis and clinical course of overactive bladder in women
by: Igor V. Kuzmin, et al.
Published: (2024)

The Association Between Urinary Tract Infection and Overactive Bladder Treatment
by: Kuang-Ming Liao, et al.
Published: (2022)

Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder
by: Rajan Rajabalaya, et al.
Published: (2016)

Intracavitary electrical stimulation as treatment for overactive bladder: systematic review
by: Rafaela Fintelman Rodrigues, et al.

Association of socioeconomic status and overactive bladder in US adults: a cross-sectional analysis of nationally representative data
by: Weilong Lin, et al.
Published: (2024)

The Effectiveness of Anticholinergic Therapy for Overactive Bladders: Systematic Review and Meta-Analysis
by: Andrea Moura Rodrigues Maciel da Fonseca, et al.
Published: (2016)